XML 16 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Net sales $ 504,666 $ 516,777 $ 1,004,717 $ 987,974
Cost of goods sold 231,367 236,545 461,431 443,713
Gross profit 273,299 280,232 543,286 544,261
Selling, general and administrative expense 213,027 205,536 407,967 395,252
Research and Development Expense 62,623 49,811 112,111 98,397
Asset Impairment Charges 0 2,360 0 2,360
Segment profit (loss) (2,351) 22,525 23,208 48,252
Interest expense 5,770 5,632 10,811 11,212
Foreign exchange losses, net 2,516 1,237 4,305 2,366
Other (income) expense, net (11,757) (11,208) (13,175) (12,385)
Income before income taxes 1,120 26,864 21,267 47,059
Provision for income taxes 3,915 (8,850) (3,819) (16,769)
Net income including noncontrolling interests     17,448 30,290
Net income attributable to Bio-Rad $ 5,035 $ 18,014 $ 17,448 $ 30,290
Basic earnings per share:        
Net income per share basic attributable to Bio-Rad $ 0.17 $ 0.61 $ 0.59 $ 1.03
Weighted average common shares - basic 29,613 29,398 29,597 29,381
Diluted earnings per share:        
Net income per share diluted attributable to Bio-Rad $ 0.17 $ 0.61 $ 0.58 $ 1.03
Weighted average common shares - diluted 30,006 29,589 29,962 29,549